These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37873108)

  • 1. Immunologic changes are detectable in the peripheral blood transcriptome of clinically asymptomatic Chagas cardiomyopathy patients.
    Duque C; So J; Castro-Sesquen YE; DeToy K; Gutierrez Guarnizo SA; Jahanbakhsh F; Machaca EM; Miranda-Schaeubinger M; Chakravarti I; Cooper V; Schmidt ME; Adamo L; Marcus R; Talaat KR; Gilman RH; Mugnier MR;
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Transcriptomic Response to
    Oliveira TGM; Venturini G; Alvim JM; Feijó LL; Dinardo CL; Sabino EC; Seidman JG; Seidman CE; Krieger JE; Pereira AC
    Front Cell Infect Microbiol; 2022; 12():904747. PubMed ID: 35873155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction.
    Ferreira LR; Ferreira FM; Nakaya HI; Deng X; Cândido DD; de Oliveira LC; Billaud JN; Lanteri MC; Rigaud VO; Seielstad M; Kalil J; Fernandes F; Ribeiro AL; Sabino EC; Cunha-Neto E
    J Infect Dis; 2017 Feb; 215(3):387-395. PubMed ID: 28003350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas disease cardiomyopathy: immunopathology and genetics.
    Cunha-Neto E; Chevillard C
    Mediators Inflamm; 2014; 2014():683230. PubMed ID: 25210230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
    Farani PSG; Begum K; Vilar-Pereira G; Pereira IR; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    Front Cell Infect Microbiol; 2021; 11():692655. PubMed ID: 34381739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Tolerance and Pathogen Resistance Genes May Underlie
    Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
    Front Immunol; 2018; 9():2791. PubMed ID: 30559742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.
    Nunes JPS; Roda VMP; Andrieux P; Kalil J; Chevillard C; Cunha-Neto E
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2062-2071. PubMed ID: 38235691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
    Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
    J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Genome Cardiac DNA Methylation Fingerprint and Gene Expression Analysis Provide New Insights in the Pathogenesis of Chronic Chagas Disease Cardiomyopathy.
    Laugier L; Frade AF; Ferreira FM; Baron MA; Teixeira PC; Cabantous S; Ferreira LRP; Louis L; Rigaud VOC; Gaiotto FA; Bacal F; Pomerantzeff P; Bocchi E; Kalil J; Santos RHB; Cunha-Neto E; Chevillard C
    Clin Infect Dis; 2017 Oct; 65(7):1103-1111. PubMed ID: 28575239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy.
    Cunha-Neto E; Kalil J
    Autoimmunity; 2001; 34(3):187-92. PubMed ID: 11908776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
    Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
    Front Immunol; 2018; 9():997. PubMed ID: 29867974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
    Silva Grijó Farani P; Iandra da Silva Ferreira B; Begum K; Vilar-Pereira G; Pereira IR; Fernández-Figueroa EA; Cardenas-Ovando RA; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011223. PubMed ID: 36972298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy.
    Santos ES; Silva DKC; Dos Reis BPZC; Barreto BC; Cardoso CMA; Ribeiro Dos Santos R; Meira CS; Soares MBP
    Front Cell Infect Microbiol; 2021; 11():765879. PubMed ID: 34869068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy.
    Frade-Barros AF; Ianni BM; Cabantous S; Pissetti CW; Saba B; Lin-Wang HT; Buck P; Marin-Neto JA; Schmidt A; Dias F; Hirata MH; Sampaio M; Fragata A; Pereira AC; Donadi E; Rodrigues V; Kalil J; Chevillard C; Cunha-Neto E
    Front Immunol; 2020; 11():1386. PubMed ID: 32733459
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies.
    Neves EGA; Koh CC; Souza-Silva TG; Passos LSA; Silva ACC; Velikkakam T; Villani F; Coelho JS; Brodskyn CI; Teixeira A; Gollob KJ; Nunes MDCP; Dutra WO
    Front Cardiovasc Med; 2022; 9():787423. PubMed ID: 35187122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 Polymorphisms as Risk Factors for Progression to Chagas Disease Cardiomyopathy: A Case-Control Study and Meta-Analysis.
    Grijalva A; Gallo Vaulet L; Agüero RN; Toledano A; Risso MG; Quarroz Braghini J; Sosa D; Ruybal P; Repetto S; Alba Soto CD
    Front Immunol; 2022; 13():946350. PubMed ID: 35860267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting imperative genes and infiltrating immune cells in chronic Chagas cardiomyopathy by bioinformatics analysis.
    Zhou L; Li Z; Li J; Yang S; Gong H
    Infect Genet Evol; 2021 Nov; 95():105079. PubMed ID: 34509648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of blood-based immune molecules with cardiac gene expression profiles reveals insights into Chagas cardiomyopathy pathogenesis.
    Souza-Silva TG; Neves EGA; Koh C; Teixeira-Carvalho A; Araújo SS; Nunes MDCP; Gomes JAS; Gollob KJ; Dutra WO
    Front Immunol; 2024; 15():1338582. PubMed ID: 38390336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins.
    Longhi SA; Atienza A; Perez Prados G; Buying A; Balouz V; Buscaglia CA; Santos R; Tasso LM; Bonato R; Chiale P; Pinilla C; Judkowski VA; Gómez KA
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2906. PubMed ID: 24901991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.